Govt panel recommends against allowing Serum Institute to conduct phase 2/3 trial of Covovax vaccine on children aged 2-17 years: Sources. PTI PLB RC

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting